Antibody-conjugated Gold Nanoparticles Research Articles

Mycotoxin Detection through Colorimetric Immunoprobing with Gold Nanoparticle Antibody Conjugates.

Driven by their exceptional optical characteristics, robust chemical stability, and facile bioconjugation, gold nanoparticles (AuNPs) have emerged as a preferred material for detection and biosensing applications in scientific research. This study involves the development of a simple, rapid, and cost-effective colorimetric immuno-sensing probe to detect aflatoxin B1 and zearalenone using AuNP antibody (AuNP-mAb) conjugates. Anti-toxin antibodies were attached to the AuNPs by using the physical adsorption method. The colorimetric immunosensor developed operates on the principle that the optical properties of the AuNP are very sensitive to aggregation, which can be induced by a critical high salt concentration. Although the presence of antibodies on the AuNP surface inhibits the aggregation, these antibodies bind to the toxin with higher affinity, which leads to exposure of the surface of AuNPs and aggregation in a salt environment. The aggregation triggers a noticeable but variable alteration in color from red to purple and blueish gray, as a result of a red shift in the surface plasmon resonance band of the AuNPs. The extent of the shift is dependent on the toxin exposure dose and can be quantified using a calibration curve through UV-Visible-NIR spectroscopy. The limit of detection using this assay was determined to be as low as 0.15 ng/mL for both zearalenone and aflatoxin B1. The specificity of the prepared immunoprobe was analyzed for a particular mycotoxin in the presence of other mycotoxins. The developed immunoprobe was evaluated for real-world applicability using artificially spiked samples. This colorimetric immunoprobe based on localized surface plasmon resonance (LSPR) has a reduced detection limit compared to other immunoassays, a rapid readout, low cost, and facile fabrication.

B-273 Clinical Validation of a Novel Lateral Flow Assay for Rapid and Sensitive Urine Fentanyl Screening

Abstract Background The urgent need for rapid fentanyl detection at the point-of-care originates from its involvement in a high number of overdose deaths, primarily due to illicit use. Given fentanyl's potency compared to traditional opioids, accurate and sensitive detection is critical. Current lateral flow assays (LFA) cannot detect single-digit concentrations and may yield false negatives due to their lower sensitivity. Herein, we evaluate the clinical performance of a novel LFA (InstaStrip Fentanyl Rapid Test (urine)) with 1 ng/mL cutoff for fentanyl and no cross-reactivity for norfentanyl, offering enhanced sensitivity for effective overdose prevention at the ED. Methods A total of 172 urine samples submitted for UDS analysis were used for comparison studies. Fentanyl concentrations were categorized in 5 groups to cover various concentration categories around the cutoff of the LFA (1 ng/mL). These categories are: drug-free (<0.1 ng/mL, n=68), 0.1-0.5 ng/mL (n=14), 0.5-0.9 ng/mL (n=15), 1-1.5 ng/mL (n=9) and > 1.5 ng/mL (n= 66). Concentrations were determined by in-house LC-MS/MS methods validated according to CLIA standards, with fentanyl concentrations quantitated in the ABSciex software. For LFA testing, 150 μL of urine was added to a reagent tube containing dried rabbit anti-fentanyl antibody conjugated gold nanoparticles. After 20 sec of brief shaking, a test strip was inserted into the test tube. After 5 min, qualitative results were read as follow: both the control and test lines were visible in negative results, whereas only the control lines were visible in positive results. Method comparison study of the LFA was conducted by three operators who were blinded to the LC-MS/MS results. Result comparisons were made between the LFA strip and LC-MS/MS results, as well as among different operators for the same samples. Results Of the 75 urine samples with LC-MS/MS fentanyl concentrations ≥ 1 ng/mL, 74 produced consistently positive results using the InstaStrip Fentanyl Rapid Test. Of the 97 urine samples with LC-MS/MS fentanyl concentrations < 1 ng/mL, 96 produced consistently negative results using the InstaStrip Fentanyl Rapid Test. Using the LC-MS/MS as the gold standard method and 1 ng/mL as a cutoff, the clinical sensitivity of InstaStrip Fentanyl Rapid Test was calculated to be 98.67% (95% confidence interval (CI) 92.79-99.97%), and the clinical specificity was 98.97% (95% CI 94.39-99.97%). Consistent results among three operators were obtained for 100% of the “drug free”, “0.1- 0.5 ng/mL” and > 1.5 ng/mL groups, whereas 93.3 % (14 out of 15) and 88.9% (7 out of 8) were obtained for the “0.5-0.9 ng/mL” and “1-1.5 ng/mL” groups, respectively. The two samples with a singlet discrepant result (1 false positive and 1 false negative) in the triplicate experiments contained fentanyl concentrations of 0.9 and 1.0 ng/mL respectively, which are very close to the cutoff value. Conclusions In this study, the InstaStrip Fentanyl Rapid Test (urine) demonstrated high clinical sensitivity (98.67%), high specificity (98.97%) and high reproducibility showing that it may be useful in screening and identifying patients with fentanyl overdose in minutes in an emergency setting. This would facilitate appropriate patient triaging for optimal clinical care.

Facile fabrication of the immuno-MALDI-MS chip for the enrichment of abused drug in human urine integrated with MALDI-MS analysis

BackgroundDrug abuse can result in both physical and mental health issues for individuals, and can also contribute to broader societal problems. The number of drug abuse cases rose to 296 million in 2021. The sample pretreatment methods commonly employed typically require longer processing times and occasionally necessitate derivatization. Furthermore, with the increase in sample sizes, traditional chromatography-mass spectrometry methods for analyzing abused drugs were no longer sufficient to handle such numerous samples. In this study, immuno-MALDI-MS chip were fabricated for specific enrichment of illicit drugs, integrating with the rapid and accurate capabilities of MALDI-MS for high-throughput analysis of drug abuse. ResultsThe immuno-MALDI-MS chip was successfully prepared by coating an aluminum chip with antibody-conjugated boronic acid-modified gold nanoparticles. Ketamine, a frequently abused illicit drug, served as the proof of concept for this study. The immuno-MALDI-MS chip was employed to selectively enrich ketamine in human urine samples, facilitating direct MALDI-MS analysis with the addition of α-CHCA matrix solution. The challenge of detecting abused drugs, exacerbated by interfering peaks in the low m/z region from salts and small molecules in human urine samples, was successfully overcome. The developed method exhibited a wide linear range of 10–5000 ng/mL with a limit of detection of 3.3 ng/mL for ketamine. Notably, the proposed method enabled high-throughput screening and accurate confirmation of ketamine concentrations in suspects' urine samples within few minutes, requiring a minimal sample volume of 1 μL. The obtained data were in complete agreement with the previous GC/MS analysis. SignificanceA straightforward, cost-effective and sensitive method for the selective enrichment and absolute quantification of abused drugs was developed using a homemade immuno-MALDI-MS chip integrated with MALDI-MS analysis. This method combines the advantages of immunoassay and mass spectrometry, offering both speed and accuracy. The reported method for the quantification of ketamine in human urine offers a practical approach and has the potential to analyze emerging new psychoactive substances in the future.

Applications of Surface Plasmon Resonance (SPR) to the Study of Diverse Protein-Ligand Interactions.

Functional characterization of enzymes/proteins requires determination of the binding affinity of small molecules or other biomolecules with the target proteins. Several available techniques, such as proteomics and drug discovery strategies, require a precise and high-throughput assay for rapid and reliable screening of potential candidates for further testing. Surface plasmon resonance (SPR), a well-established label-free technique, directly measures biomolecular affinities. SPR assays require immobilization of one interacting component (ligand) on a conductive metal (mostly gold or silver) and a continuous flow of solution containing potential binding partner (analyte) across the surface. The SPR phenomenon occurs when polarized light excites the electrons at the interface of the metal and the dielectric medium to generate electromagnetic waves that propagate parallel to the surface. Changes in the refractive index due to interaction between the ligand and analyte are measured by detecting the reflected light, providing real-time data on kinetics and specificity. A prominent use of SPR is identifying compounds in crude plant extracts that bind to specific molecules. Procedures that utilize SPR are becoming increasingly applicable outside the laboratory setting, and SPR imaging and localized SPR (LSPR) are cheaper and more portable alternative for in situ detection of plant or mammalian pathogens and drug discovery studies. LSPR, in particular, has the advantage of direct attachment to test tissues in live-plant studies. Here, we describe three protocols utilizing SPR-based assays for precise analysis of protein-ligand interactions. © 2024 Wiley Periodicals LLC. Basic Protocol 1: SPR comparison of binding affinities of viral reverse transcriptase polymorphisms Basic Protocol 2: SPR screening of crude plant extract for protein-binding agents Basic Protocol 3: Localized SPR-based antigen detection using antibody-conjugated gold nanoparticles.

Impact of synthesis methods on the functionality of antibody-conjugated gold nanoparticles for targeted therapy.

Gold nanoparticles (GNPs) are emerging as promising modular platforms for antibody-based cancer therapeutics. Their unique physiochemical properties enable efficient binding of multiple antibodies upon a single particle, thereby enhancing therapeutic potential. However, the effect of widely used synthesis techniques on the characteristics and functionality of antibody-GNP platforms has yet to be fully understood. Here, we investigated the effect of key synthesis approaches, namely, covalent binding and physical adsorption, on the properties and anti-cancer functionality of antibody-coated GNPs. By carefully manipulating synthesis variables, including antibody mass in reaction and linker compositions, we revealed a direct impact of these synthesis methods on antibody binding efficiency and anti-cancer functionality. We found that covalent binding of antibodies to GNPs generated a platform with increased cancer cell killing functionality as compared to the adsorption approach. Additionally, a higher antibody mass in the synthesis reaction and a higher polyethylene glycol linker ratio upon covalently bound antibody-GNPs led to increased cell death. Our findings emphasize the critical role of synthesis strategies in determining the functionality of targeted GNPs for effective cancer therapy.

1.4 nm gold nanoparticle-antibody conjugates for in situ gold immunolabelling after transduction into living human cells

1.4 nm gold nanoparticle-antibody conjugates for in situ gold immunolabelling after transduction into living human cells

Three-Biomarker Joint Strategy for Early and Accurate Diagnosis of Acute Myocardial Infarction via a Multiplex Electrochemiluminescence Immunoarray Coupled with Robust Machine Learning.

Acute myocardial infarction (AMI) represents a leading cause of death globally. Key to AMI recovery is timely diagnosis and initiation of treatment, ideally within 3 h of symptom onset. Cardiac troponin T (cTnT) is the gold standard yet a low cTnT result cannot rule out AMI at early times. Here, we develop a three-biomarker joint strategy for early and accurate diagnosis of AMI via an electrochemiluminescence (ECL) immunoarray coupled with robust machine learning. The ECL immunoarray is based on an array microchip with a single-electrode and chemiluminescent immuno-Gold (ciGold) nanoassemblies. The ciGold immunoarray was obtained by successively assembling nanocomposites of Cu2+/cysteine complexes and N-(aminobutyl)-N-(ethylisoluminol) bifunctionalized gold nanoparticles combined with chitosan and antibody conjugated gold nanoparticles on the surface of a microchip. Three biomarkers, including cardiac troponin I, heart type fatty acid binding protein, and copeptin, were simultaneously detected in 260 serum samples from patients presenting with chest pain by an innovative multiplexed ECL immunoarray, and classified via the three-biomarker joint assessment model using support vector machines. The model achieved perfect discrimination (100% sensitivity and specificity) for AMI vs non-AMI patients, substantially higher than cTnT alone. Within 12 h of symptom onset, high-sensitivity cardiac troponin T (hs-cTnT) misclassified >20% of patients, while the joint biomarker assessment model retained perfect accuracy. As the time between symptom onset and testing became shorter, the degree to which the joint assessment model outperformed hs-cTnT increased. The proposed three-biomarker joint strategy is obviously superior to hs-cTnT for early and accurate diagnosis of AMI, hopefully reducing AMI mortality and saving limited medical resources.

Rapid nanocatalytic reaction using antibody-conjugated gold nanoparticles for simple and sensitive detection of parathyroid hormone

Biomolecule-conjugated metal nanoparticles (NPs) have been primarily used as colorimetric labels in affinity-based bioassays for point-of-care testing. A facile electrochemical detection scheme using a rapid nanocatalytic reaction of a metal NP label is required to achieve more quantitative and sensitive point-of-care testing. Moreover, all the involved components should be stable in their dried form and solution. This study developed a stable component set that allows for rapid and simple nanocatalytic reactions combined with electrochemical detection and applied it for the sensitive detection of parathyroid hormone (PTH). The component set consists of an indium–tin oxide (ITO) electrode, ferrocenemethanol (FcMeOH), antibody-conjugated Au NPs, and ammonia borane (AB). Despite being a strong reducing agent, AB is selected because it is stable in its dried form and solution. The slow direct reaction between FcMeOH+ and AB provides a low electrochemical background, and the rapid nanocatalytic reaction allows for a high electrochemical signal. Under optimal conditions, PTH could be quantified in a wide range of concentrations in artificial serum, with a detection limit of ∼0.5 pg/mL. Clinical validation of the developed PTH immunosensor using real serum samples indicates that this novel electrochemical detection scheme is promising for quantitative and sensitive immunoassays for point-of-care testing.

Detection of Alzheimer's Disease Biomarker using Anti-NFL Antibody Conjugated Gold Nanoparticles

Hee-Won An, Chi-Yeon Song, Yu-Rim Ahn, Ji-Yeon Park, Miso Jeong, Hyun-Hee Ryu, Sukchan Lee, Hyun-Ouk Kim. Korean Society for Biotechnology and Bioengineering Journal 2022;37:123-30. https://doi.org/10.7841/ksbbj.2022.37.4.123

Citrate and glutathione capped gold nanoparticles for electrochemical immunosensing of atrazine: Effect of conjugation chemistry

Recently, the exposure of pesticides/herbicides to the living organisms is increased especially due to agricultural malpractices and industrial processes. In particular, the exposure of pesticides/herbicides (e.g., atrazine) can impart several harsh effects on the human health. The development of efficient detection systems can be crucial in monitoring the atrazine in water and food/plant products, which can be decisive in controlling the deadly exposures of atrazine. Herein, we have developed electrochemical immunosensors for atrazine by employing monoclonal anti-atrazine antibody conjugated gold nanoparticles. Two types of gold nanoparticles (i.e., citrate and glutathione (GSH)-capped AuNPs) were used to modify gold working electrode and utilized for the development of atrazine immunosensors. The conjugation of immunoprobe on working electrode was especially designed to obtain stable and efficient sensing signals. The nanosensing immunoprobes fabricated using citrate-AuNPs and GSH-AuNPs exhibited comparable responses for a wide linear working range of 50 ng/L- 30 μg/L with limit of detection (LOD) values of 0.08 and 0.06 ng/L for atrazine, respectively.

Enzymatic Formation of Recombinant Antibody-Conjugated Gold Nanoparticles in the Presence of Citrate Groups and Bacteria

With the spread of deadly diseases worldwide, the design of rapid tests to identify causative microorganisms is necessary. Due to the unique properties of gold nanoparticles, these nanoparticles are used in designing rapid diagnostic tests, such as strip tests. The current study aimed to investigate the ability of gold nanoparticles to bind to single-chain variable fragment antibodies. In this study, the biological and chemical methods included Escherichia coli TOP-10 and the Turkevich method to synthesize the gold nanoparticles, respectively. Then, the effect of synthetic nanoparticles on their capability of binding to recombinant antibodies was assessed by agarose gel and UV-vis spectroscopy. Our result showed that gold nanoparticles had a spherical morphology, and their average size was ~45 nm. Additionally, the citrate groups in gold nanoparticles were able to bind to serine residues in the antibody linker sequence; so, the chemical synthesis of gold nanoparticles is an effective strategy for binding these nanoparticles to antibodies that can be used in designing rapid diagnostic tests to promptly identify infectious microorganisms.

Anti-Cancer Activity of the Combinational Treatment of Noozone Cold Plasma with p-FAK Antibody-Conjugated Gold Nanoparticles in OSCC Xenograft Mice.

Oral squamous cell cancer (OSCC) is the most common type of oral cancer (about 80–90% of cases) and various research is being done to cure the disease. This paper aims to verify whether treatment with no-ozone cold plasma (NCP), which is designed for safe usage of the plasma on oral cavities, in combination with gold nanoparticles conjugated with p-FAK antibody (p-FAK/GNP) can trigger the selective and instant killing of SCC-25 cells both in vitro and in vivo. When SCC25 and HaCaT cells are exposed to p-FAK/GNP+NCP, the instant cell death was observed only in SCC25 cells. Such p-FAK/GNP+NCP-mediated cell death was observed only when NCP was directly treated on SCC25 harboring p-FAK/GNP. During NCP treatment, the removal of charged particles from NCP using grounded electric mesh radically decreased the p-FAK/GNP+NCP-mediated cell death. This p-FAK/GNP+NCP-mediated selective cell death of OSCC was also observed in mice xenograft models using SCC25 cells. The mere treatment of p-FAK/GNP and NCP on the xenograft tumor slowly decreased the size of the tumor, and only about 50% of the tumor remained at the end of the experiment. On the other hand, 1 week of p-FAK/GNP+NCP treatment was enough to reduce half of the tumor size, and most of tumor tissue had vanished at the end. An analysis of isolated tissues showed that in the case of individual treatment with p-FAK/GNP or NCP, the cancer cell population was reduced due to apoptotic cell death. However, in the case of p-FAK/GNP+NCP, apoptotic cell death was unobserved, and most tissues were composed of collagen. Thus, this paper suggests the possibility of p-FAK/GNP+NCP as a new method for treating OSCC.

High-performance biosensor using a sandwich assay via antibody-conjugated gold nanoparticles and fiber-optic localized surface plasmon resonance

For real-time and high-sensitivity analysis of low-concentration targets, a sandwich immunoassay using second antibody-second gold nanoparticle (2nd Ab-2nd AuNP) conjugates was combined with fiber-optic localized surface plasmon resonance (FO LSPR). An FO LSPR format was constructed by immobilizing AuNPs on a fiber-optic cross-section for compactness, portability, and ease of handling. In addition, it was combined with a microfluidic system to ensure reproducibility and reliability of measurements. A detection limit of 97.6 fg/mL (148 aM) was obtained for thyroglobulin (Tg) without a sandwich assay. The detection limit was enhanced by approximately 15 times (6.6 fg/mL, 10 aM) when a sandwich strategy was performed with a 2nd Ab-2nd AuNP signal amplifier to further improve the responsivity. Additionally, the good selectivity of the proposed method was confirmed against the unpaired antigen. To evaluate its practical applicability in the field, an FO LSPR biosensor boosted with a sandwich assay using antibody-functionalized AuNPs was applied to detect Tg contained in patient serum, and the results were compared and verified with those of a commercial radioimmunoassay kit. Based on the above results, the signal-enhancing immunoassay with FO LSPR will contribute to the development of optical biosensors for early diagnosis and preventive applications.

SERS characterization of colorectal cancer cell surface markers upon anti-EGFR treatment.

Colorectal cancer (CRC) is the third most diagnosed and the second lethal cancer worldwide. Approximately 30-50% of CRC are driven by mutations in the KRAS oncogene, which is a strong negative predictor for response to anti-epidermal growth factor receptor (anti-EGFR) therapy. Examining the phenotype of KRAS mutant and wild-type (WT) CRC cells in response to anti-EGFR treatment may provide significant insights into drug response and resistance. Herein, surface-enhanced Raman spectroscopy (SERS) assay was applied to phenotype four cell surface proteins (EpCAM, EGFR, HER2, HER3) in KRAS mutant (SW480) and WT (SW48) cells over a 24-day time course of anti-EGFR treatment with cetuximab. Cell phenotypes were obtained using Raman reporter-coated and antibody-conjugated gold nanoparticles (SERS nanotags), where a characteristic Raman spectrum was generated upon single laser excitation, reflecting the presence of the targeted surface marker proteins. Compared to the KRAS mutant cells, KRAS WT cells were more sensitive to anti-EGFR treatment and displayed a significant decrease in HER2 and HER3 expression. The SERS results were validated with flow cytometry, confirming the SERS assay is promising as an alternative method for multiplexed characterization of cell surface biomarkers using a single laser excitation system.

Antibody-conjugated gold nanoparticles as nanotransducers for second near-infrared photo-stimulation of neurons in rats

Infrared neural stimulation with the assistance of photothermal transducers holds great promise as a mini-invasive neural modulation modality. Optical nanoparticles with the absorption in the near-infrared (NIR) window have emerged as excellent photothermal transducers due to their good biocompatibility, surface modifiability, and tunable optical absorption. However, poor activation efficiency and limited stimulation depth are main predicaments encountered in the neural stimulation mediated by these nanoparticles. In this study, we prepared a targeted polydopamine (PDA)-coated gold (Au) nanoparticles with specific binding to thermo-sensitive ion channel as nanotransducers for second near-infrared (NIR-II) photo-stimulation of neurons in rats. The targeted Au nanoparticles were constructed via conjugation of anti-TRPV1 antibody with PEGylated PDA-coated Au nanoparticles and thus exhibited potent photothermal performance property in the second NIR (NIR-II) window and converted NIR-II light to heat to rapidly activate Ca2+ influx of neurons in vitro. Furthermore, wireless photothermal stimulation of neurons in living rat successfully evoke excitation in neurons in the targeted brain region as deep as 5 mm beneath cortex. This study thus demonstrates a remote-controlled strategy for neuromodulation using photothermal nanotransducers.

Highly Sensitive Voltammetric Immunosensing of Cancer Biomarkers HER2 and CA125 Using Gold Nanoparticles Anchored Reduced Graphene Oxide Enzyme-Free Nanolabel

Sandwich type voltammetric immunosensors were developed for the quantitative determination of cancer biomarkers, HER2 (human epidermal growth factor receptor 2), and CA125 (cancer antigen 125). Specific antibodies were immobilized on the gold electrodes by using a self-assembled monolayer of mercaptoundecanoic acid (MUA) activated by EDC-NHS ((1-ethyl-3-(3-dimethylamino propyl) carbodiimide and N-hydroxysuccinimide). Antibody conjugated gold nanoparticles decorated reduced graphene oxide (anti-HER2-Au/rGO and anti-CA125-Au/rGO) were used as enzyme-free nano labels for signal amplification. The sensors were characterized thoroughly by spectroscopic, microscopic, and electrochemical methods. Differential pulse voltammetric (DPV) studies in the presence of thionine revealed that the current signal produced is directly related to the biomarker concentration. A linear range of 0.2 pg ml−1 to 100 ng ml−1 was obtained, which indicated the immunosensors to be highly sensitive in lower concentrations of cancer biomarkers. Finally, the fabricated immunosensors were tested with serum samples spiked with HER2 and CA125. The results obtained from the test confirmed the data collected from clinical labs.

Gold-viral particle identification by deep learning in wide-field photon scattering parametric images.

The ability to identify virus particles is important for research and clinical applications. Because of the optical diffraction limit, conventional optical microscopes are generally not suitable for virus particle detection, and higher resolution instruments such as transmission electron microscopy (TEM) and scanning electron microscopy (SEM) are required. In this paper, we propose a new method for identifying virus particles based on polarization parametric indirect microscopic imaging (PIMI) and deep learning techniques. By introducing an abrupt change of refractivity at the virus particle using antibody-conjugated gold nanoparticles (AuNPs), the strength of the photon scattering signal can be magnified. After acquiring the PIMI images, a deep learning method was applied to identify discriminating features and classify the virus particles, using electron microscopy (EM) images as the ground truth. Experimental results confirm that gold-virus particles can be identified in PIMI images with a high level of confidence.

Automatic label-free immunoassay with high sensitivity for rapid detection of SARS-CoV-2 nucleocapsid protein based on chemiluminescent magnetic beads

Accurate and efficient early diagnosis is crucial for the control of COVID-19 pandemic. However, methods that can balance sensitivity, high throughput, detection speed and automation simultaneously are still scarce. Here, we report an automatic label-free chemiluminescence immunoassay (CLIA) for rapid SARS-CoV-2 nucleocapsid protein (NP) detection with high sensitivity and throughput. N-(4-aminobutyl)-N-ethylisoluminol and Co2+ dual-functionalized chemiluminescent magnetic beads (dfCL-MB) were first applied to the detection of protein by a novel and simple strategy. Sulphydryl polyethylene glycol was coated on the surface of dfCL-MB so as to assemble dfCL-MB and antibody conjugated gold nanoparticles through Au-S bond. Considering the high-risk application scenarios, the immunosensor was integrated with an automatic chemiluminescence analyzer so that the whole testing procedure could be carried out automatically without manual operation. A linear correlation between CL intensities and the logarithm of NP concentration was obtained in the range of 0.1–10,000 pg/mL with a detection limit of 21 fg/mL. The whole process cost 25 min and the sample compartment can bear 24 samples simultaneously. The spiked human serum samples and serum samples from COVID-19 patients were determined with satisfactory recoveries of 91.1–109.4%, suggesting that the proposed label-free CLIA is of great potential for SARS-CoV-2 NP detection in practice.

Rapid and sensitive detection of ochratoxin A using antibody-conjugated gold nanoparticles based on Localized Surface Plasmon Resonance

The regulation of tolerable levels of ochratoxin A in food for human and animal consumption has been defined in some countries. To meet these levels, simpler, more efficient, and faster analytical methods are being developed to facilitate the identification of this dangerous contaminant in food. Here, we combined gold nanoparticles (AuNPs) with anti-ochratoxin A (OTA) IgG to detect elementary levels of OTA based on Localized Surface Plasmon Resonance. AuNPs were prepared with trisodium citrate and characterized by UV–visible spectroscopy, X-ray, dynamic light scattering, and transmission electron microscopy. The conjugation of AuNPs to IgG anti-OTA was confirmed by bathochromic shift (UV–vis) and RAMAN spectroscopy. The sensitivity of the nanosensor was investigated by measuring LSPR band λmax shifts. Our results suggest this assay is highly sensitive, with a lower detection limit of about 0.001 pg mL−1. The LSPR nanosensor reduced detection limits by roughly 10 times compared to other methods. We demonstrated that the approach investigated here is a rapid and sensitive method for OTA detection.

Photothermal lateral flow immunoassay using microfiber long-period grating

Paper-based biosensors are important analytical tools in biological and chemical fields. To increase the detection limit and range, here we demonstrated a microfiber long-period grating (mLPG) based biosensor for lateral flow immunoassay (mLPG-LFIA). Compared to conventional paper-based biosensor, the mLPG with strong evanescent wave functions as an ultrasensitive tool for detecting the refractive index changes induced by the localized plasmonic heating of antibody-conjugated gold nanoparticles. The LFIA concentration level is encoded into the refractive index modulation and can be subsequently read by measuring the spectral shift of the mLPG. As proof-of-concept demonstration, quantitative analysis of heavy-metal chromium-ion concentrations ranging from of 0.195 to 200 ng/mL is performed, and a detection limit of 0.219 ng/mL is achieved. The proposed technique is sensitive, easy-to-use, and can serve as a powerful tool to analyze trace chemicals or biochemicals for application in the area of medicine, foods safety and environment monitoring.